Trytosaveabit commented on a stock · Jan 2 06:05

Results next?

$Leap Therapeutics (LPTX.US)$ Leap Therapeutics Concludes Enrollment In The Randomized Controlled Part C Of Distinguish Study Of DKN-01 In Combination With BeiGene's Tislelizumab And Chemotherapy In Patients With Advanced Gastroesophageal Junction And Gastric Cancer
Benzinga· 1 min ago

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

7470 Views

Comment

Trytosaveabit

3600Followers

23Following

53KVisitors